Clin Chem Lab Med. 2016 Aug 1;54(8):1395-401. doi: 10.1515/cclm-2015-0631.
Plasma 3-methoxytyramine (3-MT), a metabolite of dopamine, is elevated in up to 28% of patients with head and neck paragangliomas (HNPGLs). As free dopamine is incorporated in circulating platelets, we determined dopamine concentration in platelets in patients with a HNPGL.
A single center cohort study was performed between 2012 and 2014. Thirty-six patients with a HNPGL were compared to healthy controls (68 for dopamine in platelets and 120 for plasma 3-MT).
Dopamine concentration in platelets was elevated in HNPGL patients compared to healthy controls (median [interquartile ranges] 0.48 [0.32-0.82] pmol/109 platelets vs. 0.31 [0.24-0.47] pmol/109 platelets; p<0.05), whereas plasma 3-MT concentration did not differ between both groups (0.06 [0.06-0.08] nmol/L vs. 0.06 [0.06-0.06] nmol/L; p=0.119). Based on 68 healthy controls, the reference interval for dopamine concentration in platelets was 0.12-0.97 pmol/109 platelets. Six (16.7%) patients with a HNPGL demonstrated an increased dopamine concentration in platelets compared to three (8.3%) patients with an increased plasma 3-MT level (p=0.053). The sensitivity and specificity were 16.7% and 98.5% for platelet dopamine and 8.3% and 97.5% for plasma 3-MT concentration (p=0.37).
Dopamine concentration in platelets is elevated in patients with a HNPGL compared to healthy subjects, and may be a novel biomarker for dopamine producing paraganglioma.
血浆 3-甲氧基酪胺(3-MT)是多巴胺的一种代谢物,在高达 28%的头颈部副神经节瘤(HNPGL)患者中升高。由于游离多巴胺被纳入循环血小板,因此我们测定了 HNPGL 患者血小板中的多巴胺浓度。
在 2012 年至 2014 年期间进行了一项单中心队列研究。将 36 例 HNPGL 患者与健康对照者(血小板中的多巴胺为 68 例,血浆 3-MT 为 120 例)进行比较。
与健康对照组相比,HNPGL 患者的血小板多巴胺浓度升高(中位数[四分位间距]0.48[0.32-0.82]pmol/109 血小板 vs. 0.31[0.24-0.47]pmol/109 血小板;p<0.05),而两组间血浆 3-MT 浓度无差异(0.06[0.06-0.08]nmol/L vs. 0.06[0.06-0.06]nmol/L;p=0.119)。基于 68 例健康对照者,血小板多巴胺浓度的参考区间为 0.12-0.97 pmol/109 血小板。与 3 例血浆 3-MT 水平升高的患者相比(p=0.053),6 例 HNPGL 患者的血小板多巴胺浓度升高(16.7%)。血小板多巴胺的敏感性和特异性分别为 16.7%和 98.5%,血浆 3-MT 浓度的敏感性和特异性分别为 8.3%和 97.5%(p=0.37)。
与健康受试者相比,HNPGL 患者的血小板多巴胺浓度升高,可能是一种新的多巴胺产生副神经节瘤的生物标志物。